Sipuleucel-T
id:
sipuleucel-t-319-16379753
title:
Sipuleucel-T
text:
Sipuleucel-T, sold under the brand name Provenge, developed by Dendreon Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer (CaP). It is an autologous cellular immunotherapy.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Sipuleucel-T
date created:
date modified:
2023-11-25T17:07:55Z
main entity:
{"identifier":"Q424057","url":"https://www.wikidata.org/entity/Q424057"}
image:
fields total:
13
integrity:
13